// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

The impact of frailty on the outcomes of percutaneous coronary intervention (PCI) in the setting of non-ST elevation myocardial infarction

Zhihong Yao - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Use of sirolimus coated balloon in de novo small vessel coronary lesions; long-term follow-up from a single centre registry

Bhagya Harindi Loku Waduge - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

sirolimus

Long term clinical outcomes from use of sirolimus coated balloon in coronary intervention; data from a real-world population

Bhagya Harindi Loku Waduge - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

sirolimus

Drug coated balloon only angioplasty for stent thrombosis

Ioannis Merinopoulos - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Paclitaxel

Percutaneous coronary intervention in patients turned down for surgical revascularization: a single-centre experience

MOHANED EGRED - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Prasugrel loading for patients with high bleeding risk presenting with ST-segment elevation myocardial infarction referred for primary percutaneous intervention – a retrospective analysis of bleeding and mortality

Theofanis Nizamis - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

Clopidogrel bisulfate

Long term outcomes of rotational atherectomy in patients with severe left ventricular systolic dysfunction and chronic kidney disease: a 10-year United Kingdom tertiary centre experience

Joon Tan - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left ventricular dysfunction

N/A

A comparison of percutaneous and surgical revascularisation strategies following an equipoise decision in a heart team meeting

Jonathan Mailey - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Structural Heart Disease

Hydroxyzine

An unusual cause of dyspnoea diagnosed during right heart catheterisation

James O’Brien - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Rheumatoid arthritis

N/A

Use of sirolimus-coated balloon in De novo lesions; mid-term follow-up from a single-centre registry

Bhagya Harindi Loku Waduge - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

sirolimus

Left main stem percutaneous coronary intervention in a non-surgical centre – a safe and effective treatment option

Joanna Abramik - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A survey of current learning methods used by interventional cardiology trainees in the United Kingdom

Anenta Ramakrishnan - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The use of grace score to risk stratify and the outcomes of a low risk cohort with acute coronary syndrome in a district general hospital

Chaamanti Sivakumar - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

Grace

The effect of the COVID-19 pandemic on time to angiography and outcomes in patients presenting with non-ST elevation myocardial infarction

Mohammed Oshieba - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Acute kidney injury following percutaneous coronary intervention for acute coronary syndromes – incidence, aetiology, risk factors and outcomes

Elliott Carande - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Immersive clinical simulation for assessment of ultrasound-guided pericardiocentesis procedures for trainees

Kamatamu Amanda Mbonye - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac tamponade

N/A

Out of sight but not out of mind. A district hospital cardiology teleclinic setup… patients’, sustainability and environmental benefits

Zhihong Yao - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Audit of echocardiographic probability of pulmonary hypertension in a real world population referred to a specialist centre

Oliver Slegg - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Is virtual cardiology training here to stay in the post-COVID era?

Vishal Luther - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Assessment of a novel, web-based, open-access training resource for junior trainees in echocardiography

Sally Chapman - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved